These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 2395001)
1. Superior antiproliferative effects mediated by interferon-alpha entrapped in liposomes against a newly established human lung cancer cell line. Shin DM; Fidler IJ; Bucana CD; Fan D; Hong WK; Killion JJ J Biol Response Mod; 1990 Aug; 9(4):355-60. PubMed ID: 2395001 [TBL] [Abstract][Full Text] [Related]
2. Effect of liposome-encapsulated alpha- or beta-interferon on breast cancer cell lines. Coradini D; Pellizzaro C; Biffi A; Lombardi L; Pirronello E; Riva L; Di Fronzo G Anticancer Res; 1998; 18(1A):177-82. PubMed ID: 9568074 [TBL] [Abstract][Full Text] [Related]
3. Direct antiproliferative effects of recombinant human interferon-alpha B/D hybrids on human tumor cell lines. Fidler IJ; Heicappell R; Saiki I; Grutter MG; Horisberger MA; Nuesch J Cancer Res; 1987 Apr; 47(8):2020-7. PubMed ID: 3828990 [TBL] [Abstract][Full Text] [Related]
4. Heterogeneous response of human colon cancer cells to the cytostatic and cytotoxic effects of recombinant human cytokines: interferon-alpha, interferon-gamma, tumor necrosis factor, and interleukin-1. Morikawa K; Fidler IJ J Biol Response Mod; 1989 Apr; 8(2):206-18. PubMed ID: 2499665 [TBL] [Abstract][Full Text] [Related]
5. Antiproliferative and cytotoxic effects of single and combined treatment with tumor necrosis factor alpha and/or alpha interferon on a human renal cell carcinoma xenotransplanted into nu/nu mice: cell kinetic studies. Baisch H; Otto U; Klöppel G Cancer Res; 1990 Oct; 50(19):6389-95. PubMed ID: 2400997 [TBL] [Abstract][Full Text] [Related]
6. Additive and differential biological activity of alpha-interferon A, difluoromethylornithine, and their combination on established human lung cancer cell lines. Bepler G; Carney DN; Nau MM; Gazdar AF; Minna JD Cancer Res; 1986 Jul; 46(7):3413-9. PubMed ID: 3085922 [TBL] [Abstract][Full Text] [Related]
7. Augmentation of antiproliferative activity of interferon alfa against human bladder tumor cell lines by encapsulation of interferon alfa within liposomes. Killion JJ; Fan D; Bucana CD; Frangos DN; Price JE; Fidler IJ J Natl Cancer Inst; 1989 Sep; 81(18):1387-92. PubMed ID: 2778824 [TBL] [Abstract][Full Text] [Related]
8. [Antiproliferative effect of interferon-alpha on human renal cell carcinoma in clonogenic assay--single and combination effect with cancer chemotherapeutic agent]. Ohmura K; Tsukamoto T Hinyokika Kiyo; 1989 May; 35(5):737-47. PubMed ID: 2801371 [TBL] [Abstract][Full Text] [Related]
9. Liposomal delivery of alpha-Interferon to murine bladder tumor cells via transferrin receptor-mediated endocytosis. Liao WP; DeHaven J; Shao J; Chen JX; Rojanasakul Y; Lamm DL; Ma JK Drug Deliv; 1998; 5(2):111-8. PubMed ID: 19570002 [TBL] [Abstract][Full Text] [Related]
10. Effects of human recombinant alpha 2 arg-interferon and gamma-interferon on human breast cancer cell lines: dissociation of antiproliferative activity and induction of HLA-DR antigen expression. Gastl G; Marth C; Leiter E; Gattringer C; Mayer I; Daxenbichler G; Flener R; Huber C Cancer Res; 1985 Jul; 45(7):2957-61. PubMed ID: 3924395 [TBL] [Abstract][Full Text] [Related]
11. Interferon-alpha and interferon-gamma combined with chemotherapy: in vitro sensitivity studies in non-small cell lung cancer cell lines. Hand A; Pelin K; Halme M; Ekman A; Mattson M; Vallas M; Mattson K; Linnainmaa K; Husgafvel-Pursiainen K Anticancer Drugs; 1993 Jun; 4(3):365-8. PubMed ID: 8395259 [TBL] [Abstract][Full Text] [Related]
12. Effects of alpha-difluoromethylornithine and recombinant interferon-alpha 2 on the growth of a human renal cell adenocarcinoma xenograft in nude mice. Heston WD; Fleischmann J; Tackett RE; Ratliff TL Cancer Res; 1984 Aug; 44(8):3220-5. PubMed ID: 6430546 [TBL] [Abstract][Full Text] [Related]
13. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor. Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716 [TBL] [Abstract][Full Text] [Related]
14. Comparative antiproliferative activity in vitro of natural interferons alpha and beta for diploid and transformed human cells. Borden EC; Hogan TF; Voelkel JG Cancer Res; 1982 Dec; 42(12):4948-53. PubMed ID: 7139598 [TBL] [Abstract][Full Text] [Related]
15. Augmented antitumor effect of combined human natural interferon-alpha and mismatched double-stranded RNA treatment against a human malignant melanoma xenograft. Hubbell HR; Pequignot EC; Todd J; Raymond LC; Mayberry SD; Carter WA; Strayer DR J Biol Response Mod; 1987 Oct; 6(5):525-36. PubMed ID: 3681346 [TBL] [Abstract][Full Text] [Related]
16. Effect of transfection with human interferon-beta gene entrapped in cationic multilamellar liposomes in combination with 5-fluorouracil on the growth of human esophageal cancer cells in vitro. Tsunoo H; Komura S; Ohishi N; Yajima H; Akiyama S; Kasai Y; Ito K; Nakao A; Yagi K Anticancer Res; 2002; 22(3):1537-43. PubMed ID: 12168834 [TBL] [Abstract][Full Text] [Related]
17. The development of liposomes containing interferon alpha for the intravesical therapy of human superficial bladder cancer. Frangos DN; Killion JJ; Fan D; Fishbeck R; von Eschenbach AC; Fidler IJ J Urol; 1990 Jun; 143(6):1252-6. PubMed ID: 2342197 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the antitumor effects of human natural and recombinant interferons (alpha and beta) on human cancer cell lines. Motoo Y; Hill NO; Osther K Jpn J Exp Med; 1986 Feb; 56(1):13-8. PubMed ID: 3014184 [TBL] [Abstract][Full Text] [Related]
20. Stronger growth-inhibitory effect of interferon (IFN)-beta compared to IFN-alpha is mediated by IFN signaling pathway in hepatocellular carcinoma cells. Damdinsuren B; Nagano H; Wada H; Kondo M; Ota H; Nakamura M; Noda T; Natsag J; Yamamoto H; Doki Y; Umeshita K; Dono K; Nakamori S; Sakon M; Monden M Int J Oncol; 2007 Jan; 30(1):201-8. PubMed ID: 17143530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]